Importance of lymph node immune responses in MSI-H/dMMR colorectal cancer

被引:21
|
作者
Inamori, Koji [1 ,2 ,3 ,4 ,5 ]
Togashi, Yosuke [1 ]
Fukuoka, Shota [1 ]
Akagi, Kiwamu [6 ]
Ogasawara, Kouetsu [7 ]
Irie, Takuma [1 ]
Motooka, Daisuke [8 ]
Kobayashi, Yoichi [9 ,10 ]
Sugiyama, Daisuke [9 ]
Kojima, Motohiro [11 ]
Shiiya, Norihiko [3 ,4 ,5 ]
Nakamura, Shota [8 ]
Maruyama, Shoichi [10 ]
Suzuki, Yutaka [12 ]
Ito, Masaaki [2 ]
Nishikawa, Hiroyoshi [1 ,9 ]
机构
[1] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr EPOC, Div Canc Immunol, Res Inst, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan
[2] Natl Canc Ctr Hosp East NCCHE, Dept Colorectal Surg, Chiba, Japan
[3] Hamamatsu Univ, Div Cardiovasc, Surg 1, Sch Med, Hamamatsu, Shizuoka, Japan
[4] Hamamatsu Univ, Div Thorac, Surg 1, Sch Med, Hamamatsu, Shizuoka, Japan
[5] Hamamatsu Univ, Div Gen Endoscop & Breast Surg, Surg 1, Sch Med, Hamamatsu, Shizuoka, Japan
[6] Saitama Canc Ctr SCC, Div Mol Diag & Canc Prevent, Saitama, Japan
[7] Tohoku Univ, Inst Dev Aging & Canc, Dept Immunobiol, Sendai, Miyagi, Japan
[8] Osaka Univ, Res Inst Microbial Dis, Osaka, Japan
[9] Nagoya Univ, Grad Sch Med, Dept Immunol, Nagoya, Aichi, Japan
[10] Nagoya Univ, Dept Nephrol, Grad Sch Med, Nagoya, Aichi, Japan
[11] NCCHE, Div Pathol, Chiba, Japan
[12] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba, Japan
关键词
REGULATORY T-CELLS; MICROSATELLITE INSTABILITY; PD-1; BLOCKADE; CLINICOPATHOLOGICAL FEATURES; EXPRESSION; TUMORS; COLON; INFILTRATION; MULTICENTER; IMMUNOLOGY;
D O I
10.1172/jci.insight.137365
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Patients with colorectal cancers (CRCs) generally exhibit improved survival through intensive lymph node (LN) dissection. However, recent progress in cancer immunotherapy revisits the potential importance of regional LNs, where T cells are primed to attack tumor cells. To elucidate the role of regional LN, we investigated the immunological status of nonmetastatic regional LN lymphocytes (LNLs) in comparison with those of the tumor microenvironment (tumor-infiltrating lymphocytes; TILs) using flow cytometry and next-generation sequencing. LNLs comprised an intermediate level of the effector T cell population between peripheral blood lymphocytes (PBLs) and TILs. Significant overlap of the T cell receptor (TCR) repertoire was observed in microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) CRCs with high tumor mutation burden (TMB), although limited TCRs were shared between nonmetastatic LNs and primary tumors in microsatellite stable/MMR proficient (MSS/pMMR) CRC patients with low TMB. In line with the overlap of the TCR repertoire, an excessive LN dissection did not provide a positive impact on long-term prognosis in our MSI-H/dMMR CRC cohort (n = 130). We propose that regional LNs play an important role in antitumor immunity, particularly in MSI-H/dMMR CRCs with high TMB, requiring care to be taken regarding excessive nonmetastatic LN dissection in MSI-H/dMMR CRC patients.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Is MSI-H of value in predicting the development of metachronous colorectal cancer?
    Lawes, DA
    Pearson, T
    SenGupta, S
    Boulos, PB
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (04) : 473 - 476
  • [42] Neoadjuvant pembrolizumab shows promise in MSI-H/dMMR solid tumours
    Sidaway, Peter
    NATURE REVIEWS CLINICAL ONCOLOGY, 2023, 20 (03) : 138 - 138
  • [43] KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer
    Andre, Thierry
    Pietrantonio, Filippo
    Avallone, Antonio
    Gumus, Mahmut
    Wyrwicz, Lucjan
    Kim, Jong Gwang
    Yalcin, Suayib
    Kwiatkowski, Mariusz
    Lonardi, Sara
    Zolnierek, Jakub
    Odeleye-Ajakaye, Amos
    Leconte, Pierre
    Fogelman, David
    Kim, Tae Won
    FUTURE ONCOLOGY, 2023, 19 (37) : 2445 - 2452
  • [44] New first-line therapy for dMMR/MSI-H CRC
    Romero, Diana
    NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (02) : 63 - 63
  • [45] Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial)
    Okuma, Hitomi S.
    Watanabe, Keisuke
    Tsuchihashi, Kenji
    Machida, Ryunosuke
    Sadachi, Ryo
    Hirakawa, Akihiro
    Ariyama, Hiroshi
    Kanai, Masashi
    Kamikura, Masahisa
    Anjo, Kenta
    Hiramitsu, Akari
    Sekine, Shigeki
    Okita, Natsuko
    Mano, Hiroyuki
    Nishikawa, Hiroyoshi
    Nakamura, Kenichi
    Yonemori, Kan
    CLINICAL CANCER RESEARCH, 2023, 29 (24) : 5079 - 5086
  • [46] The mutational landscape of MSI-H and MSS colorectal cancer.
    Li, Enxiao
    Hu, Ying
    Han, Wenbo
    Liu, Tianshu
    Lv, Fang
    Zhao, Lili
    Liu, Yang
    Chen, Yanhui
    Zhang, Henghui
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [47] COMPANION DIAGNOSTIC ASSAYS FOR PEMBROLIZUMAB IN PATIENTS WITH MSI-H/DMMR TUMORS
    Marabelle, Aurelien
    Cesario, Jeff
    Lang, Lixin
    Aurora-Garg, Deepti
    Mathur, Siddhartha Krishan
    Levitan, Diane
    Card, Deb
    Jin, Fan
    Adelberg, David
    Andre, Thierry
    Wehn, Amy
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A569 - A569
  • [48] New first-line therapy for dMMR/MSI-H CRC
    Diana Romero
    Nature Reviews Clinical Oncology, 2021, 18 : 63 - 63
  • [49] An interpretable deep learning model for identifying the morphological characteristics of dMMR/MSI-H gastric cancer
    Zheng, Xueyi
    Jing, Bingzhong
    Zhao, Zihan
    Wang, Ruixuan
    Zhang, Xinke
    Chen, Haohua
    Wu, Shuyang
    Sun, Yan
    Zhang, Jiangyu
    Wu, Hongmei
    Huang, Dan
    Zhu, Wenbiao
    Chen, Jianning
    Cao, Qinghua
    Zeng, Hong
    Duan, Jinling
    Luo, Yuanliang
    Li, Zhicheng
    Lin, Wuhao
    Nie, Runcong
    Deng, Yishu
    Yun, Jingping
    Li, Chaofeng
    Xie, Dan
    Cai, Muyan
    Nie, Runcong
    ISCIENCE, 2024, 27 (03)
  • [50] High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon Cancer
    Mohamed, Amr
    Jiang, Renjian
    Philip, Philip A.
    Diab, Maria
    Behera, Madhusmita
    Wu, Christina
    Alese, Olatunji
    Shaib, Walid L.
    Gaines, Tyra M.
    Balch, Glen G.
    El-Rayes, Bassel F.
    Akce, Mehmet
    FRONTIERS IN ONCOLOGY, 2021, 11